We provide a comprehensive catalogue of mutations implicated in resistance to the WHO high priority drugs bedaquiline (and clofazimine) as well as an improved understanding of the underlying resistanc
Background. Namibia is among the thirty high burden tuberculosis (TB) countries with an estimated incidence of 460 per 100,000 population and around 800 new multidrug resistant (MDR) TB cases per year
